|
Volumn 2, Issue 5, 2002, Pages 483-484
|
Hybridon and Aegera collaborate to develop antisense drug.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
BIRC4 PROTEIN, HUMAN;
PROTEIN;
X LINKED INHIBITOR OF APOPTOSIS;
APOPTOSIS;
ARTICLE;
CANADA;
COOPERATION;
DRUG INDUSTRY;
ECONOMICS;
GENETICS;
HUMAN;
LICENSING;
NEOPLASM;
ORGANIZATION AND MANAGEMENT;
UNITED STATES;
APOPTOSIS;
CANADA;
COOPERATIVE BEHAVIOR;
DRUG INDUSTRY;
HUMANS;
LICENSURE;
MASSACHUSETTS;
NEOPLASMS;
OLIGONUCLEOTIDES, ANTISENSE;
PROTEINS;
X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;
|
EID: 1842836507
PISSN: 14737140
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|